Acetyl-Histone H2B (Lys5) Antibody

What is Acetyl-Histone H2B (Lys5) and what is its biological significance?

Histone H2B is one of the core components of the nucleosome, which represents the smallest subunit of chromatin consisting of 147 base pairs of DNA wrapped around an octamer of core histone proteins (two each of Histone H2A, Histone H2B, Histone H3, and Histone H4). Acetylation at lysine 5 of histone H2B (H2BK5ac) is a post-translational modification that plays a critical role in chromatin remodeling and gene expression regulation . This specific modification represents part of the complex histone code that influences DNA accessibility and transcriptional activity. When DNA associates with core histone octamers containing acetylated H2A/H2B dimers, the inhibition of transcriptional initiation decreases significantly, suggesting that acetylation of lysine residues like K5 mediates transcription . H2BK5ac is therefore considered an important epigenetic marker associated with active gene transcription.

How do Acetyl-Histone H2B (Lys5) antibodies differ from other histone modification antibodies?

Acetyl-Histone H2B (Lys5) antibodies are specifically designed to recognize histone H2B only when it is acetylated at the lysine 5 position. These antibodies demonstrate high specificity with no cross-reactivity with non-modified lysine 5 or other acetylations in histone H2B . This specificity distinguishes them from antibodies targeting other modifications like H2BK12ac, H2BK15ac, or H2BK20ac. Different from antibodies against histone H3 modifications (which are more extensively studied), H2B modification antibodies provide insights into distinct regulatory mechanisms of chromatin structure. While many histone antibodies share similar applications (ChIP, Western blot, etc.), the optimal working conditions and experimental protocols vary significantly between them, with H2BK5ac antibodies showing specific concentration requirements (WB: 0.01-1 μg/mL; ELISA: 0.2-1 μg/mL) that differ from other histone modification antibodies .

What are the major experimental applications for Acetyl-Histone H2B (Lys5) antibodies?

Acetyl-Histone H2B (Lys5) antibodies have been validated for multiple experimental applications in epigenetic research. The primary applications include:

These applications allow researchers to investigate the presence, distribution, and dynamics of H2BK5ac in various experimental contexts ranging from protein expression levels to genome-wide distribution patterns .

What species reactivity can be expected from available Acetyl-Histone H2B (Lys5) antibodies?

Most commercially available Acetyl-Histone H2B (Lys5) antibodies show broad species reactivity due to the high conservation of histone proteins across species. Based on validation data:

• Human reactivity is confirmed across all tested antibodies

• Mouse reactivity is confirmed in multiple antibodies

• Rat reactivity is reported for some antibodies

• Broader vertebrate reactivity is claimed for some products

How can Acetyl-Histone H2B (Lys5) antibodies be optimized for ChIP-Seq experiments?

ChIP-Seq optimization with Acetyl-Histone H2B (Lys5) antibodies requires careful consideration of several parameters. The modENCODE and NIH Roadmap Epigenomics Mapping Consortiums have implemented rigorous standardization criteria for ChIP-Seq assays using these antibodies . For optimal results:

• Antibody amount should be carefully titrated, with 5-10 μl per ChIP reaction serving as a starting point

• Chromatin shearing conditions should be optimized to yield fragments of 200-500 bp

• Input controls and negative controls (IgG or non-modified peptide) are essential for proper data interpretation

• Cross-linking conditions may need optimization (typically 1% formaldehyde for 10 minutes)

• Positive controls using samples known to contain the modification (e.g., HeLa cells treated with sodium butyrate) should be included

When interpreting ChIP-Seq data, researchers should consider the genomic distribution patterns of H2BK5ac, which often correlate with transcriptionally active regions. Integration with RNA-Seq or other histone modification datasets can provide comprehensive insights into the functional significance of H2BK5ac patterns .

What are the critical considerations for quantitative analysis of Acetyl-Histone H2B (Lys5) levels?

Quantitative analysis of H2BK5ac levels requires attention to several experimental variables:

• Extraction method: Acid extraction is critical for efficient isolation of histones. For Western blot analysis, acid extracts of cells (particularly HeLa cells treated with sodium butyrate as a positive control) are recommended .

• Antibody selection: Monoclonal antibodies often provide more consistent results for quantitative analyses compared to polyclonal antibodies. Clone RM455 has been specifically validated for quantitative applications .

• Normalization strategy: Quantitative analyses should include:

  • Normalization to total H2B levels using an antibody against unmodified H2B

  • Internal loading controls appropriate for histone analysis

  • Standard curves using recombinant or synthetic acetylated peptides

• Treatment conditions: Histone deacetylase inhibitors like sodium butyrate significantly increase acetylation levels and can serve as positive controls .

• Analytical platform selection: Luminex-based assays can detect H2BK5ac at concentrations as low as 0.01 μg/mL, offering superior sensitivity compared to traditional Western blotting for certain applications .

How do different histone-modifying enzymes influence Acetyl-Histone H2B (Lys5) patterns?

The acetylation status of H2BK5 is regulated by the dynamic balance between histone acetyltransferases (HATs) and histone deacetylases (HDACs):

• HATs: p300 has been identified as a primary acetyltransferase that acetylates both Histone H2A and Histone H2B, forming acetylated H2A/H2B heterodimers . Other HATs may also contribute to H2BK5 acetylation in a context-dependent manner.

• HDACs: The sensitivity of H2BK5ac to HDAC inhibitors like sodium butyrate suggests regulation by multiple HDAC family members . Class I HDACs (particularly HDAC1 and HDAC2) are likely involved in regulating this modification.

• Readers: Proteins containing bromodomains can recognize and bind to acetylated lysines in histones, including H2BK5ac, mediating downstream effects on transcription.

• Crosstalk with other modifications: The functional significance of H2BK5ac may be influenced by neighboring modifications, such as:

  • H2B monoubiquitination, which cooperates with acetylation in transcriptional regulation

  • H2B phosphorylation at Ser14, which may have antagonistic or synergistic effects depending on the cellular context

  • Methylation at other lysine residues in H2B

Understanding these enzymatic regulations helps researchers interpret changes in H2BK5ac patterns in different experimental contexts and design targeted interventions to manipulate this modification .

What is the optimal protocol for Western blot detection of Acetyl-Histone H2B (Lys5)?

For optimal Western blot detection of Acetyl-Histone H2B (Lys5), the following protocol is recommended:

• Sample preparation:

  • Extract histones using acid extraction (typically 0.2N HCl)

  • Alternatively, prepare acid extracts of HeLa cells treated with sodium butyrate as a positive control

  • For challenging samples, implement a high salt/sonication protocol, as many chromatin-bound proteins are not soluble in low salt nuclear extracts

• Gel electrophoresis and transfer:

  • Use 15-18% SDS-PAGE gels for optimal histone separation

  • Transfer to PVDF membrane at lower voltage/longer time than standard proteins

  • Consider wet transfer methods for consistent results

• Antibody incubation:

  • Block with 5% BSA in TBST

  • Incubate with Acetyl-Histone H2B (Lys5) antibody at dilutions of 1:2,000-1:10,000 or concentrations of 0.01-1 μg/mL

  • For monoclonal antibodies like RM455, a concentration of 0.02 μg/mL has been validated with HeLa cell extracts

• Detection:

  • Use HRP-conjugated secondary antibodies appropriate for the primary antibody host species

  • Implement ECL or other sensitive detection methods

  • Image using appropriate exposure times to avoid saturation

• Controls and validation:

  • Include non-treated samples alongside HDAC inhibitor-treated samples

  • Consider using peptide competition assays to confirm specificity

  • Validate with samples where H2BK5ac is known to be modified

This optimized protocol helps ensure specific detection of the H2BK5ac modification with minimal background .

How should samples be prepared for immunofluorescence detection of Acetyl-Histone H2B (Lys5)?

For immunofluorescence detection of Acetyl-Histone H2B (Lys5), sample preparation is critical:

• Cell fixation:

  • Fix cells with 4% paraformaldehyde for 10-15 minutes at room temperature

  • For some applications, methanol fixation may provide better accessibility to nuclear antigens

• Permeabilization:

  • Permeabilize with 0.1-0.5% Triton X-100 for 5-10 minutes

  • This step is crucial for antibody access to nuclear antigens

• Antigen retrieval:

  • For some fixed samples, especially tissue sections, heat-mediated antigen retrieval may improve signal

  • Consider citrate buffer (pH 6.0) treatment for 10-20 minutes

• Blocking and antibody incubation:

  • Block with 3-5% BSA or normal serum

  • Use Acetyl-Histone H2B (Lys5) antibody at dilutions of 1:50-1:500

  • Incubate overnight at 4°C for optimal results

• Detection and counterstaining:

  • Use fluorophore-conjugated secondary antibodies appropriate for visualization

  • Counterstain DNA with DAPI

  • Mount with anti-fade medium to preserve fluorescence

• Controls:

  • Include samples treated with HDAC inhibitors as positive controls

  • Use peptide competition or antibodies to non-modified H2B as specificity controls

This optimized protocol enables visualization of the nuclear distribution patterns of H2BK5ac in cultured cells and tissue sections, with recommended dilutions based on validated applications .

What controls should be included when performing ChIP experiments with Acetyl-Histone H2B (Lys5) antibodies?

ChIP experiments with Acetyl-Histone H2B (Lys5) antibodies require comprehensive controls:

• Input control:

  • Reserve 5-10% of chromatin before immunoprecipitation

  • Essential for normalizing ChIP signals and calculating percent input

  • Should be processed in parallel with immunoprecipitated samples

• Negative controls:

  • IgG control (same species as the H2BK5ac antibody)

  • Non-immune serum control

  • Non-modified peptide control where available

• Positive controls:

  • Known target regions where H2BK5ac is enriched

  • Samples treated with HDAC inhibitors (e.g., sodium butyrate)

  • Antibodies against general active chromatin marks (H3K4me3, H3K27ac) for comparison

• Technical validation:

  • Biological replicates (minimum of 3)

  • Technical replicates when possible

  • qPCR validation of enrichment at known target sites before sequencing

• Sample-specific controls:

  • For treatment studies, include appropriate vehicle controls

  • For developmental studies, include appropriate time-point controls

  • For tissue-specific studies, include appropriate tissue controls

These comprehensive controls ensure the specificity and reliability of ChIP data generated with Acetyl-Histone H2B (Lys5) antibodies, following guidelines established by the modENCODE and NIH Roadmap Epigenomics Mapping Consortiums .

What factors might contribute to inconsistent detection of Acetyl-Histone H2B (Lys5)?

Several factors can lead to inconsistent detection of Acetyl-Histone H2B (Lys5):

• Antibody-related factors:

  • Batch-to-batch variability, particularly with polyclonal antibodies

  • Degradation due to improper storage or repeated freeze-thaw cycles

  • Insufficient validation for specific applications

  • Using concentrations outside the recommended range (0.01-1 μg/mL for WB)

• Sample preparation issues:

  • Inefficient extraction of histones from chromatin

  • Inadequate fixation leading to epitope loss

  • Proteolytic degradation during sample handling

  • Dephosphorylation/deacetylation during extraction

• Experimental variables:

  • Cell culture conditions affecting acetylation status

  • Cell cycle variations in histone acetylation patterns

  • Stress responses altering histone modifications

  • Batch effects in cell treatments (particularly HDAC inhibitors)

• Technical considerations:

  • Insufficient blocking leading to high background

  • Suboptimal antibody incubation times or temperatures

  • Detection system sensitivity limitations

  • Image acquisition settings not optimized for signal range

To address these challenges, researchers should standardize protocols, use freshly prepared samples, maintain consistent cell culture conditions, and include appropriate controls in each experiment. Aliquoting antibodies to avoid repeated freeze-thaw cycles and validating each new lot with positive controls (such as HeLa cells treated with sodium butyrate) can significantly improve consistency .

How can researchers differentiate between specific and non-specific binding when using Acetyl-Histone H2B (Lys5) antibodies?

Differentiating between specific and non-specific binding requires multiple validation approaches:

• Peptide competition assays:

  • Pre-incubate the antibody with acetylated and non-acetylated peptides

  • Specific binding should be blocked by the acetylated peptide but not by the non-acetylated peptide

  • Include gradient concentrations of competing peptides to determine specificity thresholds

• Cross-reactivity testing:

  • Test against samples containing other acetylated lysines in histone H2B

  • Validated antibodies like RM455 show no cross-reactivity with non-modified Lysine 5 or other acetylations in histone H2B

• Genetic validation:

  • Use cell lines with mutations in the H2B lysine 5 residue (K5R)

  • Compare wild-type and mutant samples to confirm specificity

  • Consider HAT/HDAC knockdown or knockout models

• Multiple antibody validation:

  • Compare results using different antibody clones targeting the same modification

  • Consistent patterns across different antibodies suggest specific binding

  • Divergent results warrant further investigation

• Signal pattern analysis:

  • Specific H2BK5ac signals should show nuclear localization

  • Expected molecular weight should be ~14-18kDa in Western blots

  • ChIP-Seq patterns should correlate with known distribution of this mark

These validation strategies help ensure that observed signals genuinely represent H2BK5ac rather than antibody cross-reactivity or non-specific binding .

How should researchers interpret changes in Acetyl-Histone H2B (Lys5) levels in the context of gene expression studies?

Interpreting changes in H2BK5ac levels in gene expression studies requires a nuanced approach:

These guidelines help researchers extract meaningful biological insights from observed changes in H2BK5ac levels, connecting epigenetic modifications to functional outcomes in gene regulation .